Das Klinikum Klagenfurt am Wörthersee, ehemals Landeskrankenhaus Klagenfurt – LKH, ist ein Krankenhaus der Maximalversorgung in der Kärntner Landeshauptstadt Klagenfurt am Wörthersee. Träger ist die Kärntner Landeskrankenanstalten-Betriebsgesellschaft.

During the past decade, Klinikum Klagenfurt am Wörthersee conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 16 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 12 clinical trials were completed. i.e. 48% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Klagenfurt am Wörthersee" #1 sponsor was "Bayer" with 4 trials, followed by "Celgene" with 4 trials sponsored, "Klinikum Klagenfurt am Wörthersee" with 4 trials sponsored, "Medical University of Graz" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Klagenfurt am Wörthersee" #1 collaborator was "Klinikum Klagenfurt am Wörthersee" with 5 trials as a collaborator, "Medical University of Vienna" with 3 trials as a collaborator, "European Commission" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Johannes Kepler University of Linz" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Klagenfurt am Wörthersee" are "Ulcerative Colitis" (6 trials), "Acute Myocardial Infarction" (3 trials), "Atherosclerosis" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Klinikum Klagenfurt am Wörthersee" in a lesser frequency.

Most popular intervention types in "Klinikum Klagenfurt am Wörthersee" are "Drug" (43 trials), "Device" (11 trials), "Other" (9 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Brigatinib" (2 trials), "GED-0301" (2 trials), "Gemcitabine" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Klagenfurt am Wörthersee" are 62 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Klagenfurt am Wörthersee". undefined are not yet recruiting, 11 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Klinikum Klagenfurt am Wörthersee, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Klagenfurt am Wörthersee, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 15 trials that are defined as “Not Applicable".

Klinikum Klagenfurt am Wörthersee has several departments that took part in Clinical trials: "Klinikum Klagenfurt am Wörthersee; 2. Medizinische Abteilung" - 2 trials